학술논문

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Pulsed, Inhaled Nitric Oxide at a Dose of 30 μg/kg Ideal Body Weight/hr in Subjects at Risk of Pulmonary Hypertension Associated With Pulmonary Fibrosis Receiving Oxygen Therapy.
Document Type
journal article
Source
CHEST; Aug2020, Vol. 158 Issue 2, p637-645, 9p
Subject
PULMONARY fibrosis
PULMONARY hypertension
NITRIC oxide
IDIOPATHIC pulmonary fibrosis
INTERSTITIAL lung diseases
PERSISTENT fetal circulation syndrome
RESEARCH
RESEARCH methodology
PROGNOSIS
ACTIVITIES of daily living
MEDICAL cooperation
EVALUATION research
COMPARATIVE studies
RANDOMIZED controlled trials
PULMONARY function tests
BLIND experiment
DOSE-effect relationship in pharmacology
INHALATION administration
DISEASE complications
Language
ISSN
00123692
Abstract
Copyright of CHEST is the property of American College of Chest Physicians and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)